Patient P-02010
Synthetic patientMETA-24 · Day 111 · 35–44 · F · baseline S19Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
36%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S19
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity+14
- GI instability+13
- Inflammatory activity+11
- Nutritional resilience-5
- Treatment adherence+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable32 min
worsening · -2.7 vs previous 14 d
Sleep duration
Wearable6.2 h
stable · -0.1 vs previous 14 d
Energy level
Daily log4.5/10
worsening · -1.2 vs previous 14 d
Steps
Wearable2,979
worsening · -327 vs previous 14 d
GI burden
Companion23.3/100
worsening · +8.3 vs previous 14 d
Adherence
Companion91.7 %
stable · -1.1 vs previous 14 d
Sleep quality
Wearable38.3/100
worsening · -4.5 vs previous 14 d
Glucose, CGM daily mean
CGM134 mg/dL
stable · +5.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 68 from the failing basin, 20 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.2 next day on high-intake days · n 18
Would not help
- Keep histamine lowGI +3.2 next day on high-intake days · n 14
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+3.2detractor · 95%
- Protein-3.2supporter · 95%
- Insoluble fibre+1.1no signal · 33%
- Ultra-processed food+1no signal · 27%
- Caffeine-0.8no signal · 23%
- Simple carbohydrates-0.4no signal · 15%
- Dietary fat load-0.2no signal · 15%
- Alcohol+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓40
- Wearable2,979 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 4.3 · butyrate capacity 74/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 58 ms
- Sleep
- 6.7 h
- Steps
- 2,988
- Resting HR
- 61 bpm
Daily log: GI score 23, nutritional resilience 62, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.